Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Doriana Gramegna
Observed name:
D. Gramegna
Institution:
Istituto Tumori Bari
Observed institutions:
Harvard University,
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Dana-Farber Cancer Institute,
Istituto Tumori Bari,
Hallym University Sacred Heart Hospital,
University of Brescia
show all 6
ORCID:
0000-0003-1454-9734
Observed ORCID:
0000-0003-1454-9734
OpenAlex ID:
A5013731265
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
2018
·
Giuseppe Rossi
, Doriana Gramegna
, et al.
·
Blood
·
90
PDF
The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors
2019
·
Mariella D'Adda
, Mirko Farina
, et al.
·
Cancer
·
64
PDF
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth
2022
·
Eugenio Morelli
, Mariateresa Fulciniti
, et al.
·
Blood
·
37
PDF
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience
2021
·
Vittorio Ruggero Zilioli
, Domenico Albano
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
32
PDF
Advances in CMV Management: A Single Center Real-Life Experience
2020
·
Michele Malagola
, Caterina Pollara
, et al.
·
Frontiers in Cell and Developmental Biology
·
21
PDF
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome
2019
·
Chiara Cattaneo
, Doriana Gramegna
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
21
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
2022
·
Doriana Gramegna
, Diego Bertoli
, et al.
·
Annals of Hematology
·
20
Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
2019
·
Chiara Cattaneo
, Alessandro Busca
, et al.
·
HemaSphere
·
17
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs
2019
·
Bruno Fattizzo
, Raffaella Pasquale
, et al.
·
Haematologica
·
14
PDF
Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia
2020
·
Erika Borlenghi
, Chiara Cattaneo
, et al.
·
Hematological Oncology
·
13
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?
2020
·
Mirko Farina
, Simona Bernardi
, et al.
·
Frontiers in Oncology
·
8
PDF
Dual BCL-2/BCL-XL Inhibitor Pelcitoclax (APG-1252) Overcomes Intrinsic and Acquired Resistance to Venetoclax in Multiple Myeloma Cells
2021
·
Leona Yamamoto
, Sanika Derebail
, et al.
·
Blood
·
5
Acute promyelocytic leukemia in patients aged >70 years is not rare and highly curable: a single center series of 21 unselected patients
2018
·
Erika Borlenghi
, Chiara Cattaneo
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
Comparative Monitoring of Minimal Residual Disease (MRD) By RT-Quantitative (RT-qPCR) and Digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) Patients Treated with TKIs for Recognition of Stable Deep Molecular Response (DMR) and Identification of Best Candidates to TKIs Treatment Discontinuation
2018
·
Simona Bernardi
, Michele Malagola
, et al.
·
Blood
·
2
Bioprocessing of MIR17HG Results in Long and Short Noncoding RNAs with Targetable Tumor-Promoting Activity in Multiple Myeloma
2022
·
Eugenio Morelli
, Annamaria Gulla
, et al.
·
Blood
·
1
Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma
2021
·
Eugenio Morelli
, Mariateresa Fulciniti
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Pf688 Jak2 Allelic Ratio Impacts on Vascular Event in Myelofibrosis by Increasing the Risk of Thrombosis. a Single Center Experience on 150 Patients
2019
·
M. Farina
, M. D‘Adda
, et al.
·
HemaSphere
·
1
Ps1267 Isavuconazole in Hematological Patients: Final Results of a Real‐life Multicenter Seifem (sorveglianza Epidemiologica Delle Infezioni Nelle Emopatie) Study
2019
·
C. Cattaneo
, D. Gramegna
, et al.
·
HemaSphere
·
1
Isavuconazole in Hematological Patients: Results of a Real-Life Multicenter Seifem Study
2018
·
Chiara Cattaneo
, Doriana Gramegna
, et al.
·
Blood
·
1
Jak-2 and Nfkbia Gene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data
2018
·
Ester Pungolino
, Mariella D'adda
, et al.
·
Blood
·
1
Abstract A034: Unlocking BCMA in aggressive lymphomas: A native receptor-targeted peptide for theranostic applications
2026
·
Elisabetta Pingitore
, Khushboo Fatima
, et al.
·
Blood Cancer Discovery
Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma
2026
·
Doriana Gramegna
, Paolo Mondelli
, et al.
·
Hematological Oncology
PDF
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy
2025
·
Grazia Gargano
, Susanna Anita Pappagallo
, et al.
·
Scientific Reports
PDF
P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies
2023
·
Grazia Gargano
, Susanna Anita Pappagallo
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-194 Non-coding RNA LINC01410 interacts with the minichromosome maintenance (MCM) complex and is a dependency in multiple myeloma
2023
·
Doriana Gramegna
, Na Liu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
40
Citation count:
353
H-index:
10
I10-index:
10
Year
Topic
Type
